by Weill Cornell Medical College Prostate cancer cells. Credit: NIH Image Gallery New research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve University found that prostate cancer screening with the prostate specific antigen (PSA) blood test has remarkably favorable tradeoffs. This is particularly true for...
by Weill Cornell Medical College Prostate cancer cells. Credit: NIH Image Gallery Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate cancer. Now, researchers from Weill Cornell Medicine have found that while...
KAROLINSKA INSTITUTET IMAGE: MARTIN EKLUND, ASSOCIATE PROFESSOR AT THE DEPARTMENT OF MEDICAL EPIDEMIOLOGY AND BIOSTATISTICS AT KAROLINSKA INSTITUTET, AND TOBIAS NORDSTRÖM, ASSOCIATE PROFESSOR OF UROLOGY AT THE DEPARTMENT OF CLINICAL SCIENCES, DANDERYD HOSPITAL AT KAROLINSKA INSTITUTET. CREDIT: STEFAN ZIMMERMAN Most countries have not introduced nationwide prostate cancer screening, as current methods result in overdiagnoses and...
